Cardiovascular and bleeding outcomes in a population‐based cohort of patients with chronic immune thrombocytopenia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular and bleeding outcomes in a population‐based cohort of patients with chronic immune thrombocytopenia
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-01
DOI
10.1111/jth.14446
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis
- (2016) Indraraj Umesh Doobaree et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk
- (2016) Rutger A. Middelburg et al. Hematology
- Long-term complications of splenectomy in adult immune thrombocytopenia
- (2016) Lan-Huong Thai et al. MEDICINE
- Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study
- (2016) Jens Sundbøll et al. BMJ Open
- Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis
- (2016) Li Wang et al. Scientific Reports
- Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study
- (2015) Mette Nørgaard et al. BRITISH JOURNAL OF HAEMATOLOGY
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
- (2015) C. Neunert et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding complications in immune thrombocytopenia
- (2015) D. M. Arnold Hematology-American Society of Hematology Education Program
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
- (2014) G. Moulis et al. BLOOD
- Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
- (2014) M. Ruggeri et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
- (2013) S. Boyle et al. BLOOD
- Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
- (2013) David J. Kuter et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune Thrombocytopenia Patients Requiring Anticoagulation—Maneuvering Between Scylla and Charybdis
- (2013) Axel Matzdorff et al. SEMINARS IN HEMATOLOGY
- Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
- (2012) Mette Nørgaard et al. BRITISH JOURNAL OF HAEMATOLOGY
- Competing risks in epidemiology: possibilities and pitfalls
- (2012) Per Kragh Andersen et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Risk and prognosis of adult primary immune thrombocytopenia
- (2012) Henrik Frederiksen et al. Expert Review of Hematology
- Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
- (2011) M. Norgaard et al. BLOOD
- External review and validation of the Swedish national inpatient register
- (2011) Jonas F Ludvigsson et al. BMC PUBLIC HEALTH
- Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial
- (2011) Yukari Shirasugi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
- (2011) Yoshiyuki Kurata et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
- (2011) Bengt Zöller et al. LANCET
- Clinical Implications of Elevated Antiphospholipid Antibodies in Adult Patients with Primary Immune Thrombocytopenia
- (2011) Young-Joon Yang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
- (2010) Marianne T. Severinsen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database
- (2010) A. Sarpatwari et al. HAEMATOLOGICA
- Comorbidities in patients with persistent or chronic immune thrombocytopenia
- (2010) Cheryl Enger et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
- (2010) Gregory Cheng et al. LANCET
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review
- (2009) Page E. Abrahamson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
- (2008) F. Rodeghiero et al. BLOOD
- Antiphospholipid antibodies in adults with immune thrombocytopenic purpura
- (2008) Carole Pierrot-Deseilligny Despujol et al. BRITISH JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started